M
Mitchell Kamrava
Researcher at Cedars-Sinai Medical Center
Publications - 158
Citations - 2101
Mitchell Kamrava is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Brachytherapy & Medicine. The author has an hindex of 20, co-authored 126 publications receiving 1448 citations. Previous affiliations of Mitchell Kamrava include University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline
Junzo Chino,Christina M. Annunziata,Sushil Beriwal,Lisa Bradfield,Beth Erickson,Emma C. Fields,Kathryn Jane Fitch,Matthew M. Harkenrider,Matthew M. Harkenrider,Christine H. Holschneider,Mitchell Kamrava,Eric Leung,Lilie L. Lin,Jyoti Mayadev,Marc Morcos,Chika Nwachukwu,Daniel G. Petereit,Akila N. Viswanathan +17 more
TL;DR: This guideline reviews the evidence and provides recommendations for the indications and appropriate techniques of radiation therapy (RT) in the treatment of nonmetastatic cervical cancer and suggests brachytherapy is an essential part of definitive management and volumetric planning is recommended.
Journal ArticleDOI
Utilizing time‐driven activity‐based costing to understand the short‐ and long‐term costs of treating localized, low‐risk prostate cancer
Aaron A. Laviana,Annette M. Ilg,Darlene Veruttipong,Hung-Jui Tan,Michael A. Burke,Douglas Niedzwiecki,Patrick A. Kupelian,Christopher R. King,Michael L. Steinberg,Chandan R. Kundavaram,Mitchell Kamrava,Alan L. Kaplan,Andrew K. Moriarity,William Hsu,Daniel Margolis,Jim C. Hu,Christopher S. Saigal +16 more
TL;DR: The results of time‐driven activity‐based costing (TDABC) for competing treatments of low‐risk prostate cancer for men with prostate cancer are reported.
Journal ArticleDOI
Brachytherapy in the treatment of cervical cancer: a review.
Robyn Banerjee,Mitchell Kamrava +1 more
TL;DR: This review provides an overview of state-of-the-art gynecologic brachytherapy, with a focus on recent advances and their implications for women with cervical cancer.
Journal ArticleDOI
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy.
Stephen A. Rosenberg,Lauren E. Henke,Narek Shaverdian,K Mittauer,Andrzej P. Wojcieszynski,Andrzej P. Wojcieszynski,Craig R. Hullett,Mitchell Kamrava,James Lamb,Minsong Cao,Olga Green,Rojano Kashani,Bhudatt R. Paliwal,John E. Bayouth,Paul M. Harari,Jeffrey R. Olsen,Percy Lee,Parag J. Parikh,Michael F. Bassetti +18 more
TL;DR: This study describes the first clinical outcomes of MR-guided liver SBRT and lays the foundation for future dose escalation and adaptive treatment for liver-based primary malignancies and/or metastatic disease.
Journal ArticleDOI
High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results
Henrik Hauswald,Mitchell Kamrava,Julia M. Fallon,Pin-Chieh Wang,Sang-June Park,Thanh Van,Lalaine Borja,Michael L. Steinberg,D. Jeffrey Demanes +8 more
TL;DR: HDR monotherapy is a safe and highly effective treatment of low- and intermediate-risk prostate cancer and adapted it for use without EBRT for cases not requiring lymph node treatment.